---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-038129"
form_type: "8-K"
ticker: "ERNA"
cik: "0000748592"
company_name: "Ernexa Therapeutics Inc."
filed_at: "2024-09-25T23:59:59+00:00"
generated_at: "2026-05-31T01:57:15.101394+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Eterna raises $3.9M via 12% notes; proposes debt/warrant exchange for 38.3M shares

## Summary
- Closed $3.9M 12.0% senior convertible note private placement; net proceeds for general corporate purposes.
- Agreed to sell 1,516,997 shares at $0.75/share for $1.1M in a separate common stock private placement.
- Proposes to exchange outstanding convertible notes and warrants for ~38.3M shares, subject to stockholder approval.
- Annual meeting postponed from Sept 27 to Oct 29, 2024; stockholder proposals due Oct 5.
- Support agreements covering ~48% of outstanding shares commit to vote in favor of stockholder approval.

## SEC filing metadata
- accession: 0001493152-24-038129
- form_type: 8-K
- ticker: ERNA
- cik: 0000748592
- company_name: Ernexa Therapeutics Inc.
- filed_at: 2024-09-25T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/748592/000149315224038129/0001493152-24-038129-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/748592/000149315224038129/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-038129
- JSON: https://secwatch.observer/filing/0001493152-24-038129.json
- Plain text: https://secwatch.observer/filing/0001493152-24-038129.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.